42 related articles for article (PubMed ID: 30315385)
1. ASO Author Reflections: Proposal of Tumor Size as an Index for Biologic Factor of Resectability Status of Pancreatic Ductal Adenocarcinoma.
Miyata Y; Kishi Y
Ann Surg Oncol; 2023 Dec; 30(13):8644-8645. PubMed ID: 37689609
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Rethinking Spleen Preservation in Patients with Body Pancreatic Ductal Adenocarcinoma.
Hobeika C; Sauvanet A
Ann Surg Oncol; 2024 Jul; 31(7):4691-4692. PubMed ID: 38649552
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-minority-Serving Hospitals.
Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4373-4374. PubMed ID: 36808592
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Frailty in Pancreatic Cancers.
Zhang F; Yan Y; Ge C
Ann Surg Oncol; 2024 Jan; 31(1):545. PubMed ID: 37843665
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Unlocking the Value of Inpatient Palliative Care for Patients with Pancreatic Cancer.
Kim S; Chervu N; Premji A; Mallick S; Verma A; Ali K; Benharash P; Donahue T
Ann Surg Oncol; 2024 Feb; 31(2):1362-1363. PubMed ID: 38063981
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.
Mahmud O; Javed AA; Fatimi AS; Habib A; Grewal M; He J; Wolfgang CL; Besselink MG;
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38767804
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision.
Elshami M; Ocuin LM
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38907137
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: A Novel Mechanism of Anticancer Effect of Skeletal Muscle-Derived Irisin in Pancreatic Ductal Adenocarcinoma.
Sugimoto T; Iwagami Y; Kobayashi S; Yamanaka C; Sasaki K; Yamada D; Tomimaru Y; Asaoka T; Noda T; Takahashi H; Shimizu J; Doki Y; Eguchi H
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38722421
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Utilization of Disaggregated Data Unmasks Differences in Pancreatic Cancer Outcomes in the Asian American Population.
Kooragayala K; Lou J; Hong YK
Ann Surg Oncol; 2024 Feb; 31(2):1360-1361. PubMed ID: 37930498
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Expanding Guideline Concordant Care: The Time for a National Accreditation Program for Pancreatic Cancer is Now.
Murimwa GZ; Meier J; Nehrubabu M; Khan S; Polanco PM
Ann Surg Oncol; 2023 Jul; 30(7):4388-4389. PubMed ID: 36943526
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Preoperative Imaging Findings to Predict Postoperative Pancreatic Fistula: Adding Another Tool to the Surgeon's Toolbox.
Sok C; Shah MM
Ann Surg Oncol; 2024 Apr; 31(4):2660-2661. PubMed ID: 38123731
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery.
Ando Y; Goggins M
Ann Surg Oncol; 2024 May; 31(5):2961-2962. PubMed ID: 38280960
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Identifying and Understanding How Vulnerable Populations Are Affected by Delays in Pancreatic Cancer Care.
Fallon J; Standring O; Vithlani N; Demyan L; Shah M; Gazzara E; Hartman S; Pasha S; King DA; Herman JM; Weiss MJ; DePeralta D; Deutsch G
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38847982
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Hounsfield Unit on Preoperative Computed Tomography as a Predictive Factor of Postoperative Pancreatic Fistula.
Kim SH; Kim SS; Hwang HK; Kang CM; Choi JY; Kim KS; Kim HI
Ann Surg Oncol; 2023 Nov; 30(12):7762-7763. PubMed ID: 37566287
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Improving Outcomes and Minimizing Variability in Pancreatic Cancer Care: A Study of Ontario and the United States.
Saadat LV; Wei AC
Ann Surg Oncol; 2024 Mar; 31(3):1937-1938. PubMed ID: 37865939
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung Adenocarcinoma.
Yang X; Zhong WZ
Ann Surg Oncol; 2023 Nov; 30(12):7499-7500. PubMed ID: 37581852
[No Abstract] [Full Text] [Related]
17. ASO Visual Abstract: To Revise or Not to Revise? Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma.
Elshami M; Wu VS; Stitzel HJ; Hue JJ; Loftus AW; Kyasaram RK; Shanahan J; Ammori JB; Hardacre JM; Ocuin LM
Ann Surg Oncol; 2024 Jul; ():. PubMed ID: 38972928
[No Abstract] [Full Text] [Related]
18. Author Correction: Studying the impact of marital status on diagnosis and survival prediction in pancreatic ductal carcinoma using machine learning methods.
Chen Q; Hu Y; Lin W; Huang Z; Li J; Lu H; Dai R; You L
Sci Rep; 2024 Mar; 14(1):6911. PubMed ID: 38519617
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.
Zhang SR; Li H; Wang WQ; Liu L; Yu XJ
Ann Surg Oncol; 2018 Dec; 25(13):3994-3995. PubMed ID: 30315385
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
